3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
2
Gastrointestinal
1
Conditions
Breast Neoplasms
9
Colorectal Neoplasms
6
Ovarian Neoplasms
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Prostatic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Sarcoma
1
Lung Neoplasms
1
Liposarcoma
1
Esophageal Squamous Cell Carcinoma
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinosarcoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Adenocarcinoma Of Esophagus
1
Interventions
Sampling Studies
1
Fulvestrant
1
Drugs, Generic
1
Crizotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Lobular
×
Fulvestrant
×
Gastrointestinal
×
Clear all
NCT03620643
2025-10-30
ROLo
Royal Marsden NHS Foundation Trust
Phase 2
Completed
33 enrolled
13 charts